Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Saved in:
| Title: | Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study. |
|---|---|
| Authors: | Beldi-Ferchiou A; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France., Jais JP; Biostatistics Unit, APHP, Univ Paris Descartes, Paris, France., Ghesquieres H; Hematology, Centre Hospitalier Lyon Sud, PIERRE-BENITE, Lyon, France., Casasnovas RO; Hematology, CHU Dijon Bourgogne and INSERM U 1231, Dijon, France., Tilly H; INSERM U918, Centre Henri Becquerel, Rouen, France., Fruchart C; Institut d'Hématologie de Basse Normandie, CHU Caen, Caen, France., Morschhauser F; Clinical Hematology, Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Haioun C; Lymphoid Malignancies Unit, APHP, Hopital Henri Mondor, Creteil, France., Lazarovici J; Clinical Hematology, Gustave Roussy Cancer Center, Villejuif, France., Perrot A; Hematology department, CHU Brabois, Vandoeuvre les Nancy, France., Nicolas-Virelizier E; Onco Hematology, Centre Leon Berard, Lyon, France., Salles G; Hematology, Centre Hospitalier Lyon Sud, PIERRE-BENITE, Lyon, France., Godard N; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France., Zamali I; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France., De Colella JS; Onco Hematology, Institut Paoli Calmettes, Marseille, France., Claudel A; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France., Corront B; Hematology, CH Annecy Genevois, Epagny Metz-Tessy, France., Oberic L; Hematology, IUC - Oncopole CHU Toulouse, Toulouse, France., Briere J; Pathology, APHP, Hopital Saint-Louis, Paris, France., Gaulard P; AP-HP, Henri Mondor Hospital, Pathology Department, Créteil, France.; Univ Paris Est Créteil, INSERM, IMRB, Créteil, France., Thieblemont C; Assistante publique - Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, DMU DHI, Université de Paris, Paris, France., Delfau-Larue MH; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France. |
| Source: | British journal of haematology [Br J Haematol] 2023 Apr; Vol. 201 (2), pp. 256-266. Date of Electronic Publication: 2023 Feb 06. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.18642 |
